One half million patients suffer from colorectal cancer in industrialized nations, yet this disease exhibits a low incidence in underdeveloped countries. This geographic imbalance suggests an environmental contribution to the resistance of endemic populations to intestinal neoplasia. A common epidemiological characteristic of these colon cancer-spared regions is the prevalence of enterotoxigenic bacteria associated with diarrheal disease. Here, a bacterial heat-stable enterotoxin was demonstrated to suppress colon cancer cell proliferation by a guanylyl cyclase C-mediated signaling cascade. The heat-stable enterotoxin suppressed proliferation by increasing intracellular cGMP, an effect mimicked by the cellpermeant analog 8-br-cGMP. The antiproliferative effects of the enterotoxin and 8-br-cGMP were reversed by L-cis-diltiazem, a cyclic nucleotide-gated channel inhibitor, as well as by removal of extracellular Ca 2؉ , or chelation of intracellular Ca 2؉ . In fact, both the enterotoxin and 8-br-cGMP induced an L-cis-diltiazem-sensitive conductance, promoting Ca 2؉ influx and inhibition of DNA synthesis in colon cancer cells. Induction of this previously unrecognized antiproliferative signaling pathway by bacterial enterotoxin could contribute to the resistance of endemic populations to intestinal neoplasia, and offers a paradigm for targeted prevention and therapy of primary and metastatic colorectal cancer.
C
olorectal cancer is the fourth leading cause of cancer and cancer-related mortality in the world, with a geographic distribution primarily affecting patients in developed countries ( Fig. 1a; ref. 1 ). Although the epidemiology of this disease remains poorly understood, there is an unexplained inverse relationship between the incidence of colorectal cancer and enterotoxigenic Escherichia coli (ETEC) infections (Fig. 1a) . Indeed, the age-adjusted incidence of colorectal cancer is lowest in under-developed countries (1) , where ETEC infections are the highest ( Fig. 1a; refs. 2 and 3).
ETEC produce heat-stable enterotoxins (STs; refs. 4 and 5), a principle cause of secretory diarrhea in endemic populations, travelers, and agriculturally important animal herds (6, 7) . These enterotoxins are plasmid-encoded small (Յ19 amino acids) peptides that bind to guanylyl cyclase C (GC-C), specifically expressed in intestinal epithelial cells (4, 8) . Association of STs with the extracellular domain of GC-C activates the intracellular catalytic domain that converts GTP into cGMP (9, 10) . The second messenger cGMP, in turn, activates cGMP-dependent protein kinase (PKG) II, the conventional downstream effector for this cyclic nucleotide, resulting in secretory diarrhea (9) (10) (11) . In this way, STs represent molecular mimicry wherein enterotoxigenic bacteria have evolved a strategy for dissemination and propagation that exploits normal intestinal physiology. Indeed, STs are structurally and functionally homologous to the endogenous peptides guanylin and uroguanylin (12, 13) , which mediate autocrine͞paracrine control of intestinal fluid and electrolyte homeostasis (14) .
Beyond volume homeostasis, GC-C and its ligands have been implicated in the regulation of the balance of proliferation and differentiation along the crypt-to-villus axis in the intestine (15) .
Expression of endogenous GC-C ligands is frequently lost during tumorigenesis, and subsequent loss of signaling may represent one key mutational event underlying neoplastic transformation in the colon (16) (17) (18) . In principle, this putative role for GC-C as a tumor suppressor may contribute to the inverse epidemiological association between colorectal cancer (1) and ETEC infections (2, 3) reflecting, in part, longitudinal exposure in underdeveloped countries to ST-producing bacteria. However, the mechanisms by which STs repress colorectal tumorigenesis are unknown. The present study revealed a previously unrecognized ST-induced cGMP-dependent signaling pathway, through cyclic nucleotide-gated (CNG) channels and calcium, responsible for the antiproliferative action of bacterial enterotoxins on human colon carcinoma cells.
Materials and Methods
Cell Culture. T84 (passages 50-70) and SW480 (passage 100-120) human colon carcinoma cells, obtained from the American Type Culture Collection, were maintained at 37°C (5% CO 2 ) in DMEM͞F12 containing 2.5 mM L-glutamine, 100 units͞ml penicillin, 100 g͞ml streptomycin, and 10% (vol͞vol) FBS.
DNA Synthesis. Exponentially growing cancer cells (Ϸ60% confluent in 96-well plates) were synchronized by serum starvation in Eagle's minimal essential medium (EMEM) for 48 h, followed by proliferative induction with 10 mM L-glutamine (in EMEM) for 24 h. ST and other agents were added to cells 15 min before 0.2 Ci per well (1 Ci ϭ 37 GBq) of [methyl-3 H]thymidine, which was added for 3 h, followed by quantification of [ 3 H]thymidine incorporation into DNA (15) .
Current Measurements. The perforated mode of the whole-cell patch-clamp recording was applied to human T84 colon cancer cells. Membrane potential was controlled through the electrical access obtained by membrane perforation induced by amphotericin B (9, 10 Cyclic Nucleotides. cGMP and cAMP were quantified in exponentially growing T84 cells (Ϸ60% confluent in 96-well plates) employing ELISA (Amersham Pharmacia) or RIA. In experiments employing ELISA, media was aspirated, reactions were terminated by the addition of a lysis solution (200 l per well) containing 0.5% dodecyltrimethylammonium bromide, and aliquots (100 l) from each well were processed for cyclic nucleotide determinations. In experiments employing RIA, reactions were terminated with ice-cold 100% ethanol, and supernatants were separated from pellets by centrifugation and processed for cGMP determinations (8) . for the last 15 min. Incubations were terminated by washing four times in cold PBS buffer (145 mM NaCl͞5 mM KCl͞1 mM MgCl 2 ͞10 mM glucose͞5 mM Hepes, pH 7.4) containing 0.1 mM EGTA, cells were solubilized with cold NaOH (0.1 M), and radioactivity was quantified in 100-l aliquots.
Results and Discussion
ST inhibited DNA synthesis in human colon cancer cells that express GC-C, but not in tumor cells deficient in GC-C (Fig. 1b) . The concentration-dependence of ST inhibition of proliferation corresponded to the accumulation of intracellular cGMP [cGMP] i , but not other cyclic nucleotides (Fig. 1c ). Yet, selective inhibitors of PKG, which disrupt ST induction of intestinal secretion (20) , did not prevent the antiproliferative action of the enterotoxin (Fig. 1d) . Moreover, inhibitors of cAMP-dependent protein kinase or cGMP-regulated phosphodiesterase 3 did not influence inhibition of proliferation by ST (Fig. 1d) . Thus, the antiproliferative actions of ST on human colon carcinoma cells were not mediated by conventional downstream effectors of cGMP.
Rather, a specific reversible inhibitor of CNG channels, L-DLT (21), prevented ST inhibition of proliferation (Fig. 1d) . In fact, ST induced membrane current in voltage-clamped human colon cancer cells that was reversibly blocked by L-DLT, indicating that the enterotoxin activates CNG channels (Fig. 2 a  and b) . Throughout the range of the imposed membrane potential ramp, ST significantly increased current, an effect largely reversed by L-DLT (Fig. 2c) . Although the reversal potential (E m ) of colon cancer cells was Ϫ39.3 Ϯ 3.9 mV (n ϭ 6), ST shifted E m to Ϫ66.3 Ϯ 3.6 mV (n ϭ 6; Fig. 2c ), an effect abolished by L-DLT that restored E m to Ϫ39.5 Ϯ 5.2 mV (n ϭ 4; Fig. 2c ). The action of ST on membrane current in colon cancer cells was mimicked by the membrane-permeant cGMP analog, 8-brcGMP, which also induced an L-DLT-sensitive current and produced a significant shift in E m (⌬E m ϭ Ϫ25.8 Ϯ 4.6 mV, n ϭ 3; Fig. 3 a-c) . Moreover, 8-br-cGMP inhibited tumor cell DNA synthesis in an L-DLT sensitive manner (Fig. 3d) Fig. 4 a-c) . As a further indicator of Ca 2ϩ entry, Ca 2ϩ -dependent K ϩ current (K Ca ), previously reported in this cancer cell line (23) and identified here by sensitivity to the specific blocker charybdotoxin, was found to be induced by both ST and 8-br-cGMP (Fig. 4c) . In accordance, reversal potentials derived from the ST-and 8-br-cGMP-induced current-voltage relationships approached Ϫ70 mV (Figs. 2c, 3b , and 4c Inset), which closely approximates the theoretical equilibrium potential for K entry through CNG channels was demonstrated by direct measurement of radioactive calcium flux into colon cancer cells that was inhibited by L-DLT (Fig. 4d) .
The essential role of Ca 2ϩ influx in the ST-mediated regulation of cancer cell proliferation is underscored by reversal of ST antiproliferative action through cytosolic Ca 2ϩ chelation with BAPTA-AM (Fig. 4e) ] ext restored in a concentration-dependent manner the antiproliferative effect of ST (Fig. 4f ) . In fact, ionomycin, a Ca 2ϩ ionophore, mimicked, whereas dantrolene, which blocks Ca 2ϩ release from intracellular pools, or phenamil, an inhibitor of ST induced a significant shift of the reversal potential (⌬E m ϭ Ϫ27.5 Ϯ 2.6 mV, n ϭ 6, mean Ϯ SEM) that was reversed by L-DLT. electrogenic Na ϩ influx, did not affect the ability of ST to inhibit cancer cell proliferation (Fig. 4e) . The absence of charybdotoxin effect on ST inhibition of cancer cell proliferation further indicates that Ca 2ϩ entry rather than the consequent Ca 2ϩ -sensitive K ϩ current is required for enterotoxin-mediated antiproliferation (Fig. 4e) . Thus, ST inhibits DNA synthesis in colon carcinoma cells by a signaling mechanism initiated by activation of GC-C, accumulation of [cGMP] i , and Ca 2ϩ influx through CNG channels.
cGMP is emerging as an important regulator of cell proliferation, although the molecular mechanisms mediating that activity appear to be varied and cell-specific. Thus, in human vascular smooth muscle cells, cGMP delays the G 1 ͞S transition by down-regulation of cyclin D1 and cyclin-dependent kinase 4 activities after platelet-derived growth factor stimulation (25) . Also, cGMP suppresses human T cell proliferation by inhibiting IL-2 release (26). In addition, proliferation of glomerular mesangial cells by phorbol 12,13-dibutyrate-mediated activation of mitogen-activated protein kinase is antagonized by cGMPinduced expression of the specific phosphatase MKP-1 (27) . Further, in colorectal cancer cells, the antiproliferative effects of cGMP may reflect activation of apoptotic pathways (28, 29) or regulation of cell cycle (15) . Conversely, cGMP-dependent activation of PKG promotes human umbilical vein endothelial cell proliferation by stimulating Raf-1 kinase activity (30) .
In the present study, proliferation of intestinal epithelial cells was suppressed by a signaling mechanism initiated by ST interaction with GC-C. Indeed, cells that lack this receptor͞enzyme molecule and do not exhibit ST-induced accumulation of (Fig. 1c) , activation of cAMP-dependent protein kinase, or inhibition of phosphodiesterase 3 (Fig. 1d) . This report details the regulation of cell proliferation by a cGMP-dependent mechanism mediated by CNG channels.
Ca 2ϩ serves as the third messenger in the signaling cascade linking GC-C at the cell surface to regulation of proliferation in the nucleus. Indeed, the ability of the second messenger cGMP to inhibit DNA synthesis was mediated by [Ca 2ϩ ] ext influx through CNG channels (see Fig. 4 d-f ). cGMP-dependent CNG channel-mediated Ca 2ϩ influx has been described in excitable cells, although it mediates different functions. In this way, in cone and rod photoreceptors, high [cGMP] i sustains dark-state functions, in part, by inducing Ca 2ϩ influx through CNG channels (33) . Similarly, in the brain, cGMP-dependent activation of CNG channels regulates neurotransmitter release and potentiates synaptic transmission through Ca 2ϩ influx (34) . Additionally, regulation of intracellular Ca 2ϩ by cGMP has been described in several cell systems, including vascular smooth muscle (35) , platelets (36) , and neurons (37) . In intestinal cells, ST activation of GC-C mobilizes intracellular Ca 2ϩ by a cGMPdependent mechanism (38, 39) . Further, ST and 8-br-cGMP induce Ca 2ϩ influx through CNG channels in colon (40) . In close agreement, the present study demonstrates that ST and 8-br-cGMP induce a structurally and functionally compartmentalized influx of Ca 2ϩ through CNG channels in human colon carcinoma cells. Indeed, cGMP does not evoke electrophysiologically detectable Ca 2ϩ currents in these cells (41) , although its influx could be detected with radioactive Ca 2ϩ . The precise mode of Ca 2ϩ delivery to its intracellular site of action to induce intestinal cell cytostasis remains undefined. Yet, this antiproliferative process must be tightly regulated because Ca 2ϩ can, upon intracellular accumulation, promote apoptosis (42), which is not induced by ST (15) .
In summary, these data demonstrate that bacterial enterotoxins suppress colon carcinoma cells through a GC-C-based calcium-dependent signaling pathway with a newly identified role in regulating cell proliferation. Endogenous GC-C ligands, guanylin and uroguanylin, may activate this pathway and promote the transition from proliferation to differentiation of enterocytes along the crypt-villus axis in normal intestine (15) . In addition, these observations offer a possible mechanistic insight into the resistance to colorectal cancer observed in geographic areas in which ETEC is endemic. Although additional factors contribute to the epidemiology of colorectal cancer (43, 44) , the significance of this antiproliferative pathway is highlighted by the neoplastic transformation of epithelial cells that follows loss of expression of endogenous GC-C ligands in the intestine (16) (17) (18) .
In turn, the conservation of GC-C itself and its downstream effectors by colorectal tumors provides a therapeutic target for restoration of this signaling cascade and maintenance of the tumor-suppressor phenotype. Indeed, oral administration of GC-C ligands or downstream effectors of that pathway, such as calcium, offer a hitherto unknown approach to the primary prevention of intestinal neoplasia and͞or therapy of colorectal cancer metastases (29, (45) (46) (47) .
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